FELIMAZOLE 1.25 MG COATED TABLETS FOR CATS

Држава: Ирска

Језик: Енглески

Извор: HPRA (Health Products Regulatory Authority)

Купи Сада

Активни састојак:

THIAMAZOLE

Доступно од:

Dechra Limited

АТЦ код:

QH03BB02

INN (Међународно име):

THIAMAZOLE

Дозирање:

1.25 mg/tablet

Фармацеутски облик:

Coated Tablets

Тип рецептора:

POM

Терапеутска група:

Feline

Терапеутска област:

Thiamazole

Терапеутске индикације:

Miscellaneous

Статус ауторизације:

Authorised

Датум одобрења:

2013-09-13

Карактеристике производа

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Felimazole 1.25 mg Coated tablets for cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Coated tablet.
Red sugar-coated biconvex tablets 5.5 mm diameter.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the stabilisation of hyperthyroidism in cats prior to surgical
thyroidectomy.
For the long-term treatment of feline hyperthyroidism.
4.3 CONTRAINDICATIONS
Do not use in cats suffering from systemic disease such as primary
liver disease or diabetes mellitus.
Do not use in cats showing signs of autoimmune disease.
Do not use in animals with disorders of white blood cells, such as
neutropenia and lymphopenia.
Do not use in animals with platelet disorders and coagulopathies
(particularly thrombocytopenia).
Do not use in cats with hypersensitivity to thiamazole or the
excipient, polyethylene glycol.
Do not use in pregnant or lactating females.
Please refer to section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As thiamazole can cause haemoconcentration, cats should always have
access to drinking water.
1 tablet contains:
ACTIVE SUBSTANCE:
Thiamazole
1.25 mg
EXCIPIENTS:
Titanium Dioxide (E171)
0.51 mg
Dispersed Ponceau 4R Lake (E124)
1.35 mg
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_5_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_0_
_6_
_2_
_p_
_a_
_g_
                                
                                Прочитајте комплетан документ
                                
                            

Обавештења о претрази у вези са овим производом

Погледајте историју докумената